Nezam Altorok - Concepedia

Author

Nezam Altorok

University of Toledo ORCID

Also Known As

N. Altorok, NEZAM ALTOROK, Nezam AlTorok, Nezam Altorok, Nezam Altorok, MD, Nezam Ibrahim Altorok

101

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of Toledo University of Michigan University of Toledo Medical Center University of Oklahoma Health Sciences Center McGill University

About

Nezam Altorok is an author at University of Toledo specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	393
2	Public Health	1	1	19
3	Allergy	1	1	13
4	Biostatistics	1	1	54
5	Hospital Medicine	1	1	19

Nezam Altorok

Publications

Citations

H-Index

Page 1

	Year	Citations
Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patients Patrick Coit, Matlock A. Jeffries, Nezam Altorok, Journal of Autoimmunity ChromatinAutoimmune DiseaseLupusGeneticsEpigenetic Change	2013	307
Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension Dinesh Khanna, Heather Gladue, Richard N. Channick, Arthritis & Rheumatism	2013	211
Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies Nezam Altorok, Pei-Suen Tsou, Patrick Coit, Annals of the Rheumatic Diseases	2014	170
Genome‐Wide DNA Methylation Patterns in Naive CD4+ T Cells From Patients With Primary Sjögren's Syndrome Nezam Altorok, Patrick Coit, Travis K. Hughes, Arthritis & Rheumatology	2013	170
Identification of potential genomic biomarkers for Sjögren’s syndrome using data pooling of gene expression microarrays Sadik Khuder, Ibtisam Al‐Hashimi, Anand B. Mutgi, Rheumatology International RheumatologyData PoolingGene Expression MicroarraysAutoimmune DiseaseSjögren’s Syndrome	2014	54
Patient-reported outcome instruments for assessing Raynaud’s phenomenon in systemic sclerosis: A SCTC vascular working group report John D Pauling, Tracy Frech, Michael Hughes, Journal of Scleroderma and Related Disorders	2018	41
Initial MEWS score to predict ICU admission or transfer of hospitalized patients with COVID-19: A retrospective study William Barnett, Muthukumar Radhakrishnan, John Macko, Journal of Infection Retrospective StudyAcute CareClinical EpidemiologyPatient SafetyCovid-19 Pandemic	2020	19
Successful Treatment of ANCA-Associated Vasculitis in the Setting of Common Variable Immunodeficiency Using Rituximab Frank Ernest Hill, Jennifer R. Yonkof, Sri Krishna Chaitanya Arudra, American Journal of Therapeutics VasculitisSuccessful TreatmentImmunologyImmunodeficiency DiagnosisPathology	2015	13
Genome-wide DNA methylation pattern in systemic sclerosis microvascular endothelial cells: Identification of epigenetically affected key genes and pathways Shadia E. Nada, Bashar Kahaleh, Nezam Altorok Journal of Scleroderma and Related Disorders	2021	13
Evaluation of topical econazole nitrate formulations with potential for treating Raynaud’s phenomenon Dherya Bahl, Saloni Daftardar, Rinda Devi Bachu, Pharmaceutical Development and Technology	2019	12

Page 1